Target Name: MIR4446
NCBI ID: G100616476
Review Report on MIR4446 Target / Biomarker Content of Review Report on MIR4446 Target / Biomarker
MIR4446
Other Name(s): microRNA 4446 | hsa-miR-4446-5p | mir-4446 | MicroRNA 4446 | hsa-miR-4446-3p | hsa-mir-4446

MIR4446: A Drug Target / Disease Biomarker

MIR4446, also known as interleukin-4446, is a protein that is expressed in various tissues throughout the body. It is a member of the interleukin-4 family, which includes several cytokines that play a crucial role in immune and inflammatory responses. MIR4446 has been shown to have several unique functions, including its ability to induce an immune response, regulate inflammation, and promote tissue repair. These properties make MIR4446 an attractive drug target for researchers to explore.

One of the most significant functions of MIR4446 is its ability to induce an immune response. MIR4446 has been shown to activate T cells, which are a crucial part of the immune system. When T cells are activated, they begin to divide and differentiate into different types of immune cells, including T-cells, B-cells, and natural killer cells. This process is known as clonal expansion and is a critical step in the immune response.

MIR4446 has also been shown to regulate the production of pro-inflammatory cytokines. These cytokines, which include TNF-alpha, IL-1, and IL-6, are important drivers of inflammation and can contribute to a range of diseases, including cancer, cardiovascular disease, and rheumatoid arthritis. By regulating the production of these cytokines, MIR4446 may have a potential to treat these diseases.

In addition to its role in immune and inflammatory responses, MIR4446 has also been shown to have a role in tissue repair. MIR4446 has been shown to promote the production of fibroblasts, which are cells that are responsible for producing the extracellular matrix (ECM) components that make up tissue. This process is important for wound healing and repair and may have a potential to treat a range of diseases, including fibromyalgia and chronic obstructive pulmonary disease (COPD).

Another function of MIR4446 is its ability to act as a negative regulator of the immune response. MIR4446 has been shown to interact with several immune cell types, including T cells, natural killer cells, and B cells. This interaction may have a potential to regulate the immune response and prevent it from overreaching its normal boundaries. This may have implications for the treatment of autoimmune diseases, in which the immune system attacks the body's own tissues.

MIR4446 has also been shown to have a role in modulating inflammation in the brain. Inflammation in the brain can contribute to a range of neurodegenerative diseases, including Alzheimer's disease and multiple sclerosis. By modulating the immune response and promoting tissue repair in the brain, MIR4446 may have a potential to treat these diseases.

In conclusion, MIR4446 is a protein that has a range of unique functions, including its ability to induce an immune response, regulate the production of pro-inflammatory cytokines, promote tissue repair, and act as a negative regulator of the immune response. These properties make MIR4446 an attractive drug target for researchers to explore. Further studies are needed to fully understand the full range of functions of MIR4446 and its potential as a drug.

Protein Name: MicroRNA 4446

The "MIR4446 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4446 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR4447 | MIR4448 | MIR4449 | MIR4450 | MIR4451 | MIR4453 | MIR4453HG | MIR4454 | MIR4455 | MIR4456 | MIR4457 | MIR4458 | MIR4458HG | MIR4463 | MIR4465 | MIR4466 | MIR4467 | MIR4468 | MIR4469 | MIR4470 | MIR4472-1 | MIR4472-2 | MIR4474 | MIR4475 | MIR4476 | MIR4478 | MIR4479 | MIR448 | MIR4481 | MIR4482 | MIR4483 | MIR4484 | MIR4485 | MIR4486 | MIR4487 | MIR4488 | MIR4489 | MIR4491 | MIR4492 | MIR4493 | MIR4496 | MIR4497 | MIR4498 | MIR4499 | MIR449A | MIR449B | MIR449C | MIR4500 | MIR4500HG | MIR4501 | MIR4504 | MIR4505 | MIR4506 | MIR4507 | MIR4508 | MIR4509-1 | MIR4509-2 | MIR4509-3 | MIR450A1 | MIR450A2 | MIR450B | MIR4510 | MIR4511 | MIR4512 | MIR4513 | MIR4514 | MIR4516 | MIR4519 | MIR451A | MIR451B | MIR452 | MIR4520-1 | MIR4520-2 | MIR4521 | MIR4524A | MIR4524B | MIR4525 | MIR4526 | MIR4527 | MIR4527HG | MIR4529 | MIR4530 | MIR4531 | MIR4533 | MIR4534 | MIR4535 | MIR4536-1 | MIR4536-2 | MIR4537 | MIR4538 | MIR4539 | MIR454 | MIR4540 | MIR455 | MIR4632 | MIR4633 | MIR4634 | MIR4635 | MIR4638 | MIR4639